New PKU formula aims for smoother blood control
Disease control
Terminated
This study tested if a new prolonged-release amino acid formula (PKU GOLIKE) could provide steadier control of blood phenylalanine (Phe) levels compared to standard care in people with PKU. Twenty-one adults with PKU tried both treatments at home for short periods in a crossover …
Phase: NA • Sponsor: APR Applied Pharma Research s.a. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC